- $322.03bn
- $386.79bn
- $56.33bn
- 93
- 33
- 77
- 76
REG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(a) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG-BARCLAYS PLC Form 8.3 - Abbvie Inc - Amendment
AnnouncementREG-Norges Bank: Form 8.3 - AbbVie Inc
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE INC
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (a) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (a) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE PLC
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG-Norges Bank: Form 8.3 - AbbVie Inc
Announcement